About
Lumabs develops the RAPPID platform, a bioluminescence-based immunoassay technology that enables rapid, sensitive, and quantitative detection of antibodies or antigens directly in biological samples without complex sample preparation.
Explore Lumabs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.